Medidata Stock Up in IPO

HDM Breaking News, June 25, 2009

The stock price of clinical trials software vendor Medidata Solutions Inc. rose more than 28% at the open of trading today following an initial public offering.

The New York-based company sold 6.3 million shares of stock at $14 per share, a dollar more than the original target price. The stock opened at $18 per share and by late morning was trading around $17.

The IPO is valued at $88.2 million, and up to $101.43 million if underwriters purchase another 945,000 shares to cover over-allotments.

Medidata has had strong revenue growth but heavy losses since 2004. The company in 2008 lost $18.3 million on revenue of $105.7 million, up 68%. The company's software enables the electronic capture, management and reporting of clinical trials data. Medidata in 2008 acquired Fast Track Systems Inc., a vendor of software to aid in designing, building, negotiating, budgeting and managing trials. More information is available at mdsol.com.

--Joseph Goedert

For more information on related topics, visit the following channels:

• Electronic Health Records
• Practice Management
• Revenue Cycle Management
• Vendor News
• Hospitals
• Group Practices
• Payers